NEA, RA Capital lead $85M B round for Black Diamond

Less than a month after its launch by Versant Ventures, Black Diamond Therapeutics Inc. (Cambridge, Mass.) has raised a tranched $85 million series B round to bring its two lead assets into the clinic and prepare it for an IPO in about a year.

New Enterprise Associates and RA Capital Management co-led the financing. Fellow new investors NexTech Invest, Invus Group and Perceptive Advisors joined Versant in the round...